Joint pricing negotiations are not only gathering pace in Europe as Latin American countries from the Mercosur trade bloc have together negotiated a lower price for trastuzumab. However, the company that markets the originator drug, Herceptin, has expressed doubts about how productive joint pricing negotiations really are in addressing access issues.
Joint Price Negotiations Move Ahead In Latin America
Latin American countries are continuing to pursue a strategy of jointly negotiating medicine prices to get a better deal on expensive medicines. However, manufacturers have expressed doubt that this is the best way forward.
